Search for a rare disease
Other search option(s)
ALG2-CDG
Disease definition
A form of congenital disorders of N-linked glycosylation characterized by iris coloboma, cataract, infantile spasms, developmental delay and abnormal coagulation factors. The disease is caused by loss-of-function mutations in the gene ALG2 (9q31.1). Transmission is autosomal recessive.
ORPHA:79326
Classification level: Disorder- Synonym(s):
- CDG syndrome type Ii
- CDG-Ii
- CDG1I
- Carbohydrate deficient glycoprotein syndrome type Ii
- Congenital disorder of glycosylation type 1i
- Congenital disorder of glycosylation type Ii
- Mannosyltransferase 2 deficiency
- Prevalence: <1 / 1 000 000
- Inheritance: Autosomal recessive
- Age of onset: Infancy, Neonatal
- ICD-10: E77.8
- ICD-11: 5C54.0
- OMIM: 607906
- UMLS: C1842836
- MeSH: C000623088
- GARD: 9836
- MedDRA: -
A summary on this disease is available in Español (2016) Français (2016) Italiano (2016) Nederlands (2016) Deutsch (2006)
Detailed information
Disease review articles
- Clinical genetics review
- English (2017) - GeneReviews


Additional information
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.